Real-World Effectiveness and Safety of Upadacitinib Plus Vedolizumab vs Upadacitinib Monotherapy During Induction in Moderate-to-Severe Ulcerative Colitis
Clinical trial NCT07442045 · RECRUITING
Trial details
- NCT number
- NCT07442045
- Sponsor
- Sixth Affiliated Hospital, Sun Yat-sen University
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-01-01
- Primary completion
- 2025-11-30
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.